The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma
Open accessAbstract
Purpose: Reports detailing the prognostic impact of TP53 mutations in medulloblastoma offer conflicting conclusions. We resolve this issue through the inclusion of molecular subgroup profiles. Patients and Methods: We determined subgroup affiliation, TP53 mutation status, and clinical outcome in a discovery cohort of 397 medulloblastomas. We subsequently validated our results on an independent cohort of 156 medulloblastomas. Results: TP53 mutations are enriched in wingless (WNT; 16%) and sonic hedgehog (SHH; 21%) medulloblastomas and are virtually absent in subgroups 3 and 4 tumors (P < .001). Patients with SHH/TP53 mutant tumors are almost exclusively between ages 5 and 18 years, dramatically different from the general SHH distribution (P < .001). Children with SHH/TP53 mutant tumors harbor 56% germline TP53 mutations, which are not observed in children with WNT/TP53 mutant tumors. Five-year overall survival (OS; ± SE) was 41% ± 9% and 81% ± 5% for patients with SHH medulloblastomas with and without TP53 mutations, respectively (P < .001). Furthermore, TP53 mutations accounted for 72% of deaths in children older than 5 years with SHH medulloblastomas. In contrast, 5-year OS rates were 90% ± 9% and 97% ± 3% for patients with WNT tumors with and without TP53 mutations (P = .21). Multivariate analysis revealed that TP53 status was the most important risk factor for SHH medulloblastoma. Survival rates in the validation cohort mimicked the discovery results, revealing that poor survival of TP53 mutations is restricted to patients with SHH medulloblastomas (P = .012) and not WNT tumors. Conclusion: Subgroup-specific analysis reconciles prior conflicting publications and confirms that TP53 mutations are enriched among SHH medulloblastomas, in which they portend poor outcome and account for a large proportion of treatment failures in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular subgroups of medulloblastoma: the current consensus
Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936
Self-citationMedulloblastoma Comprises Four Distinct Molecular Variants
Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S., Bouffet, E., Clifford, S. C., Hawkins, C. E., French, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4324 · Cited by 1,339
Self-citationKool, M., Korshunov, A., Remke, M., Jones, D. T. W., Schlanstein, M., Northcott, P. A., Cho, Y.-J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0958-8 · Cited by 1,056
Self-citationPacker, R. J., Gajjar, A., Vezina, G., Rorke-Adams, L., Burger, P. C., Robertson, P. L., Bayer, L., LaFond, D., Donahue, B. R., Marymont, M. H., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4980 · Cited by 989
Gajjar, A., Chintagumpala, M., Ashley, D., Kellie, S., Kun, L. E., Merchant, T. E., Woo, S., Wheeler, G., Ahern, V., Krasin, M. J., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70867-1 · Cited by 951
Self-citationSubgroup-specific structural variation across 1,000 medulloblastoma genomes
Northcott, P. A., Shih, D. J. H., Peacock, J., Garzia, L., Sorana Morrissy, A., Zichner, T., Stütz, A. M., Korshunov, A., Reimand, J., Schumacher, S. E., et al. (2012) · Nature · doi:10.1038/nature11327 · Cited by 899
Self-citationSequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
Molenaar, J. J., Koster, J., Zwijnenburg, D. A., van Sluis, P., Valentijn, L. J., van der Ploeg, I., Hamdi, M., van Nes, J., Westerman, B. A., van Arkel, J., et al. (2012) · Nature · doi:10.1038/nature10910 · Cited by 870
Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865
Self-citationNovel mutations target distinct subgroups of medulloblastoma
Robinson, G., Parker, M., Kranenburg, T. A., Lu, C., Chen, X., Ding, L., Phoenix, T. N., Hedlund, E., Wei, L., Zhu, X., et al. (2012) · Nature · doi:10.1038/nature11213 · Cited by 846
Self-citationDissecting the genomic complexity underlying medulloblastoma
Jones, D. T. W., Jäger, N., Kool, M., Zichner, T., Hutter, B., Sultan, M., Cho, Y.-J., Pugh, T. J., Hovestadt, V., Stütz, A. M., et al. (2012) · Nature · doi:10.1038/nature11284 · Cited by 839
Self-citationMedulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Pugh, T. J., Weeraratne, S. D., Archer, T. C., Pomeranz Krummel, D. A., Auclair, D., Bochicchio, J., Carneiro, M. O., Carter, S. L., Cibulskis, K., Erlich, R. L., et al. (2012) · Nature · doi:10.1038/nature11329 · Cited by 750
Self-citationKool, M., Koster, J., Bunt, J., Hasselt, N. E., Lakeman, A., van Sluis, P., Troost, D., Meeteren, N. S.-V., Caron, H. N., Cloos, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003088 · Cited by 722
Self-citationCho, Y.-J., Tsherniak, A., Tamayo, P., Santagata, S., Ligon, A., Greulich, H., Berhoukim, R., Amani, V., Goumnerova, L., Eberhart, C. G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5148 · Cited by 717
Self-citationGenomics Identifies Medulloblastoma Subgroups That Are Enriched for Specific Genetic Alterations
Thompson, M. C., Fuller, C., Hogg, T. L., Dalton, J., Finkelstein, D., Lau, C. C., Chintagumpala, M., Adesina, A., Ashley, D. M., Kellie, S. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4974 · Cited by 668
Self-citationA bootstrap resampling procedure for model building: Application to the cox regression model
Sauerbrei, W., & Schumacher, M. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111607 · Cited by 600
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
Ellison, D. W., Dalton, J., Kocak, M., Nicholson, S. L., Fraga, C., Neale, G., Kenney, A. M., Brat, D. J., Perry, A., Yong, W. H., et al. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0800-8 · Cited by 563
Self-citationVillani, A., Tabori, U., Schiffman, J., Shlien, A., Beyene, J., Druker, H., Novokmet, A., Finlay, J., & Malkin, D. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70119-x · Cited by 423
Self-citationRapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples
Northcott, P. A., Shih, D. J. H., Remke, M., Cho, Y.-J., Kool, M., Hawkins, C., Eberhart, C. G., Dubuc, A., Guettouche, T., Cardentey, Y., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0899-7 · Cited by 382
Self-citationMalkin, D., Jolly, K. W., Barbier, N., Look, A. T., Friend, S. H., Gebhardt, M. C., Andersen, T. I., Børresen, A.-L., Li, F. P., Garber, J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262002 · Cited by 379
Self-citationThe clinical implications of medulloblastoma subgroups
Northcott, P. A., Korshunov, A., Pfister, S. M., & Taylor, M. D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.78 · Cited by 328
Self-citationEllison, D. W., Kocak, M., Dalton, J., Megahed, H., Lusher, M. E., Ryan, S. L., Zhao, W., Nicholson, S. L., Taylor, R. E., Bailey, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2810 · Cited by 302
Self-citationExpression of p53 and Prognosis in Children with Malignant Gliomas
Pollack, I. F., Finkelstein, S. D., Woods, J., Burnham, J., Holmes, E. J., Hamilton, R. L., Yates, A. J., Boyett, J. M., Finlay, J. L., & Sposto, R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012224 · Cited by 281
Self-citationAdult Medulloblastoma Comprises Three Major Molecular Variants
Remke, M., Hielscher, T., Northcott, P. A., Witt, H., Ryzhova, M., Wittmann, A., Benner, A., von Deimling, A., Scheurlen, W., Perry, A., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.34.9373 · Cited by 258
Self-citationTP53 Alterations Determine Clinical Subgroups and Survival of Patients With Choroid Plexus Tumors
Tabori, U., Shlien, A., Baskin, B., Levitt, S., Ray, P., Alon, N., Hawkins, C., Bouffet, E., Pienkowska, M., Lafay-Cousin, L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8169 · Cited by 247
Self-citationTrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors
Grotzer, M. A., Janss, A. J., Fung, K.-M., Biegel, J. A., Sutton, L. N., Rorke, L. B., Zhao, H., Cnaan, A., Phillips, P. C., Lee, V. M.-Y., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1027 · Cited by 223
Jakacki, R. I., Burger, P. C., Zhou, T., Holmes, E. J., Kocak, M., Onar, A., Goldwein, J., Mehta, M., Packer, R. J., Tarbell, N., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.2792 · Cited by 217
Self-citationExcessive genomic DNA copy number variation in the Li–Fraumeni cancer predisposition syndrome
Shlien, A., Tabori, U., Marshall, C. R., Pienkowska, M., Feuk, L., Novokmet, A., Nanda, S., Druker, H., Scherer, S. W., & Malkin, D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802970105 · Cited by 203
Self-citationMagrangeas, F., Avet-Loiseau, H., Munshi, N. C., & Minvielle, S. (2011) · Blood · doi:10.1182/blood-2011-03-344069 · Cited by 181
FSTL5 Is a Marker of Poor Prognosis in Non-WNT/Non-SHH Medulloblastoma
Remke, M., Hielscher, T., Korshunov, A., Northcott, P. A., Bender, S., Kool, M., Westermann, F., Benner, A., Cin, H., Ryzhova, M. V., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2798 · Cited by 157
Self-citationUniversal Poor Survival in Children With Medulloblastoma Harboring Somatic TP53 Mutations
Tabori, U. Y., Baskin, B., Shago, M., Alon, N., Taylor, M. D., Ray, P. N., Bouffet, É., Malkin, D. M., & Hawkins, C. E. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5952 · Cited by 154
Self-citationPfaff, E., Remke, M., Sturm, D., Benner, A., Witt, H., Milde, T., von Bueren, A. O., Wittmann, A., Schöttler, A., Jorch, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1670 · Cited by 107
Self-citationRapid Diagnosis of Medulloblastoma Molecular Subgroups
Schwalbe, E. C., Lindsey, J. C., Straughton, D., Hogg, T. L., Cole, M. F., Megahed, H., Ryan, S. L., Lusher, M. E., Taylor, M. D., Gilbertson, R. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2210 · Cited by 81
Self-citationFrank, A. J., Hernán, R., Hollander, A. B., Lindsey, J. C., Lusher, M. E., Fuller, C. E., Clifford, S. C., & Gilbertson, R. J. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.11.016 · Cited by 68
Self-citationTissue-specific expression of SV40 in tumors associated with the Li–Fraumeni syndrome
Malkin, D. M., Chilton‐MacNeill, S., Meister, L., Sexsmith, E., Diller, L., & Garcea, R. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204583 · Cited by 64
Self-citationMalkin, D. M., Friend, S. H., Li, F. P., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361018 · Cited by 24
Self-citation
Cited by
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cavalli, F. M. G., Remke, M., Rampasek, L., Peacock, J., Shih, D. J. H., Luu, B., Garzia, L., Torchia, J., Nor, C., Morrissy, A. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.005 · Cited by 1,219
Self-citationSahm, F., Schrimpf, D., Stichel, D., Jones, D. T. W., Hielscher, T., Schefzyk, S., Okonechnikov, K., Koelsche, C., Reuss, D. E., Capper, D., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30155-9 · Cited by 852
Self-citationRisk stratification of childhood medulloblastoma in the molecular era: the current consensus
Ramaswamy, V., Remke, M., Bouffet, E., Bailey, S., Clifford, S. C., Doz, F., Kool, M., Dufour, C., Vassal, G., Milde, T., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1569-6 · Cited by 654
Self-citationEnhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Northcott, P. A., Lee, C., Zichner, T., Stütz, A. M., Erkek, S., Kawauchi, D., Shih, D. J. H., Hovestadt, V., Zapatka, M., Sturm, D., et al. (2014) · Nature · doi:10.1038/nature13379 · Cited by 642
Self-citationCancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534
Self-citation
Metadata
- Authors
- Zhukova, N., Ramaswamy, V., Remke, M., Pfaff, E., Shih, D. J. H., Martin, D. C., Castelo-Branco, P., Baskin, B., Ray, P. N., Bouffet, E., von Bueren, A. O., Jones, D. T. W., Northcott, P. A., Kool, M., Sturm, D., Pugh, T. J., Pomeroy, S. L., Cho, Y.-J., Pietsch, T., Gessi, M., Rutkowski, S., Bognar, L., Klekner, A., Cho, B.-K., Kim, S.-K., Wang, K.-C., Eberhart, C. G., Fevre-Montange, M., Fouladi, M., French, P. J., Kros, M., Grajkowska, W. A., Gupta, N., Weiss, W. A., Hauser, P., Jabado, N., Jouvet, A., Jung, S., Kumabe, T., Lach, B., Leonard, J. R., Rubin, J. B., Liau, L. M., Massimi, L., Pollack, I. F., Shin Ra, Y., Van Meir, E. G., Zitterbart, K., Schüller, U., Hill, R. M., Lindsey, J. C., Schwalbe, E. C., Bailey, S., Ellison, D. W., Hawkins, C., Malkin, D., Clifford, S. C., Korshunov, A., Pfister, S., Taylor, M. D., & Tabori, U.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-08-10
- Volume
- 31
- Issue
- 23
- Pages
- 2927-2935
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129331946
- Cited by
- 485
- References
- 35
- FWCI
- 14.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.